low-dose erythropoietin to stimulate endothelial precursor cells, regenerate organs and slow progression of target organ damage

摘要

LOW DOSAGE OF ERYTHROPOETIN TO STUMBLE ENDOTHIAL PRECURSOR CELLS, REGENERATE ORGANS AND REMOVE PROGRESSION OF DAMAGE IN TARGET ORGANS. The present invention relates to the use of low dose erythropoietin to stimulate physiological mobilization, proliferation and deferencing of endothelial precursor cells, to stimulate vasculogenesis, to therapy of diseases linked to endothelial precursor cell dysfunction, and to the preparation pharmaceutical compositions for the treatment of such diseases and pharmaceutical compositions containing erythropoietin and other active substances suitable for stimulating endothelial precursor cells.